Yusuke Tanetsugu

Safety profile of bosutinib in Japanese versus non-Japanese patients with chronic myeloid leukemia: a pooled analysis

T. Brümmendorf, G. Rosti, N. Takahashi, 2022, International Journal of Hematology.

Safety profile of bosutinib in Japanese versus non-Japanese patients with chronic myeloid leukemia: a pooled analysis

T. Brümmendorf, G. Rosti, N. Takahashi, 2022, International Journal of Hematology.

Bosutinib in Japanese patients with newly diagnosed chronic-phase chronic myeloid leukemia: final 3-year follow-up results of a phase 2 study

M. Hino, K. Ishizawa, I. Matsumura, 2022, International Journal of Hematology.

Phase 2 study of bosutinib in Japanese patients with newly diagnosed chronic phase chronic myeloid leukemia

M. Hino, N. Takahashi, K. Ishizawa, 2019, International Journal of Hematology.

Bosutinib in Japanese patients with newly diagnosed chronic-phase chronic myeloid leukemia: final 3-year follow-up results of a phase 2 study

M. Hino, K. Ishizawa, I. Matsumura, 2022, International Journal of Hematology.

Phase 2 study of bosutinib in Japanese patients with newly diagnosed chronic phase chronic myeloid leukemia

M. Hino, N. Takahashi, K. Ishizawa, 2020, International Journal of Hematology.